BIOMAT Database Logo BIOMAT Database Logo

Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. 2023

Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Operating Theatre, Kailuan General Hospital, Tangshan, China.

The purpose of this study was to evaluate the effect of abdominal obesity and chronic inflammation on risk of non-alcoholic fatty liver disease (NAFLD) among Chinese population. Overall, 50776 staff from the Kailuan Group who participated in and finished physical examinations between 2006 and 2007 were included in the cohort study. Their medical information was collected and they were followed after examination. The correlations of waist-to-height ratio (WHtR) or serum high-sensitivity C-reactive protein (hs-crp) with NAFLD were analyzed. Then, we categorized all participants into four groups: non-abdominal obesity and non-chronic inflammation group, abdominal obesity and non-chronic inflammation group, non-abdominal obesity and chronic inflammation group, abdominal obesity and chronic inflammation group, and non-abdominal obesity and non-chronic inflammation group was used as a control group. The combined effects of abdominal obesity and chronic inflammation with NAFLD were analyzed using the Cox proportional hazard regression model. After a mean follow-up of 5.59±1.79 years, a total of 15451 NAFLD cases occurred. We found the WHtR and hs-crp increase the risk for NAFLD, respectively. Compared with the non-abdominal obesity and non-chronic inflammation group, the risk of NAFLD was significantly increased in the abdominal obesity and non-chronic inflammation group (HR 1.21, 95%CI 1.11-1.32), non-abdominal obesity and chronic inflammation group (HR 1.32, 95%CI 1.27-1.38), abdominal obesity and chronic inflammation group (HR 1.60, 95% CI 1.52-1.70). And, a significant interaction effect was found of abdominal obesity and chronic inflammation on NAFLD. In this study, it was demonstrated in the Chinese population that both abdominal obesity and chronic inflammation increase the risk of NAFLD, and there is an interaction between the two factors in the incidence of NAFLD.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D065626 Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. Fatty Liver, Nonalcoholic,NAFLD,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Fatty Livers, Nonalcoholic,Liver, Nonalcoholic Fatty,Livers, Nonalcoholic Fatty,Non alcoholic Fatty Liver Disease,Nonalcoholic Fatty Liver,Nonalcoholic Fatty Livers,Nonalcoholic Steatohepatitides,Steatohepatitides, Nonalcoholic,Steatohepatitis, Nonalcoholic

Related Publications

Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.
September 2004, Journal of clinical gastroenterology,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Non-alcoholic fatty liver disease and childhood obesity.
April 2007, Indian journal of pediatrics,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Non-alcoholic fatty liver disease and childhood obesity.
January 2021, Archives of disease in childhood,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver.
January 2016, Advanced biomedical research,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
The Risk of Abdominal Obesity according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men.
March 2016, Journal of Korean medical science,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity.
January 2014, Journal of clinical and diagnostic research : JCDR,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.
April 2019, Liver international : official journal of the International Association for the Study of the Liver,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Adipose tissue, obesity and non-alcoholic fatty liver disease.
June 2017, Minerva endocrinologica,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Childhood obesity and adult non-alcoholic fatty liver disease.
July 2020, Liver international : official journal of the International Association for the Study of the Liver,
Dongna Zhao, and Haozhe Cui, and Zhiqiang Shao, and Liying Cao
Non-alcoholic fatty liver disease, obesity and other illnesses.
October 2008, Clinical and investigative medicine. Medecine clinique et experimentale,
Copied contents to your clipboard!